MedWatch

Danish Medicines Agency considers reporting Europharma DK again

Already once this year, the Danish Medicines Agency reported the parallel importer Europharma DK to the police. Now, the agency considers reporting the company again after a new suspension of Europharma’s authorization for secondary repackaging and release of medicinal products.

Foto: Colourbox

Once again, the Esbjerg-based parallel importer Europharma DK has been ordered to stop its manufacturing and distribution of drugs to the Danish market.

This is according to the Danish Medicines Agency after an inspection on September 21 revealed the company’s failure to meet the quality demands.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier